Dimethyl sulfoxide inhibits NLRP3 inflammasome activation - PubMed (original) (raw)

. 2014 Apr;219(4):315-22.

doi: 10.1016/j.imbio.2013.11.003. Epub 2013 Nov 22.

Affiliations

Dimethyl sulfoxide inhibits NLRP3 inflammasome activation

Huijeong Ahn et al. Immunobiology. 2014 Apr.

Abstract

Dimethyl sulfoxide (DMSO) is an amphipathic molecule that is commonly/widely used as a solvent for biological compounds. In addition, DMSO has been studied as a medication for the treatment of inflammation, cystitis, and arthritis. Based on the anti-inflammatory characteristics of DMSO, we elucidated the effects of DMSO on activation of inflammasomes, which are cytoplasmic multi-protein complexes that mediate the maturation of interleukin (IL)-1β by activating caspase-1 (Casp1). In the present study, we prove that DMSO attenuated IL-1β maturation, Casp1 activity, and ASC pyroptosome formation via NLRP3 inflammasome activators. Further, NLRC4 and AIM2 inflammasome activity were not affected, suggesting that DMSO is a selective inhibitor of the NLRP3 inflammasomes. The anti-inflammatory effect of DMSO was further confirmed in animal, LPS-endotoxin sepsis and inflammatory bowel disease models. In addition, DMSO inhibited LPS-mediating IL-1s transcription. Taken together, DMSO shows anti-inflammatory characteristics, attenuates NLRP3 inflammasome activation, and mediates inhibition of IL-1s transcription.

Keywords: Cytokine; DMSO; Inflammasome; Interleukin-1; Macrophages; NLRP3.

Crown Copyright © 2013. Published by Elsevier GmbH. All rights reserved.

PubMed Disclaimer

Comment in

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources